Vinge has advised Triton Smaller Mid Cap Fund II in connection with the acquisition of Prenax from LBO France and certain minority shareholders.

Prenax is a leading subscriptions management service provider. The company was founded in 1993 and today manages the administration of over 340,000 subscriptions on behalf of its clients. Prenax has offices in 11 countries across the UK & Benelux, the Nordics, Southern Europe, the US, and Australia. 

The transaction is subject to regulatory approvals.

Vinge’s team mainly consisted of Johanna Wiberg, Egil Svensson, Michella Lina Said and Hedvig Merkel (M&A), David Olander and Lovisa Arpi (Regulatory), August Ahlin (Banking and Finance), Mario Saad and Jacob Eberil (Agreements), William Karo Persson (Employment), Carla Håkansson (IT), Siri Blomberg (GDPR), Arvid Axelryd and Melinda Oldenburg (IP), Simon Gille-Johnson (Real Estate), Hayaat Ibrahim (Compliance), Diana Kanold (Transaction Support Coordinator).

Read the client’s press release.

Related

Vinge advises Cantargia in connection with the sale of immunology program CAN10

Vinge advises Cantargia AB (publ) in connection with the sale of its early-clinical stage IL1RAP immunology program CAN10 to the Japanese healthcare company Otsuka Pharmaceutical.
July 21, 2025

Vinge has assisted PulPac in connection with it obtaining a €20 million financing from the European Investment Bank

Vinge has assisted Gothenburg-based sustainable packaging technology company PulPac in connection with it obtaining a €20 million (around 220 million Swedish kronor) financing from the European Investment Bank (EIB).
July 18, 2025

Vinge has advised Behold Ventures in the fundraising of Behold Ventures’ first-time fund

Behold Ventures held its final closing on 27 June 2025, thereby securing investor commitments to its first-time fund amounting to approximately SEK 550 million from an international investor base, comprising the European Investment Fund (EIF), among others.
July 10, 2025